{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:32:38Z","timestamp":1792373558455,"version":"4.4.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Artif. Intell."],"abstract":"<jats:p>\n                    The development of vaccines and immunotherapies against infectious diseases and cancers has been one of the significant achievements of medical science in the last century. Subunit vaccines offer key advantages over whole-inactivated or attenuated-pathogen-based vaccines, as they elicit more specific B-and T-cell responses with improved safety, immunogenicity, and protective efficacy. However, developing subunit vaccines is often cost-and time-consuming. In the past, the development of vaccines and immunotherapeutics relied heavily on trial-and-error experimentation, as well as extensive and costly\n                    <jats:italic>in vivo<\/jats:italic>\n                    testing, which typically required years of pre-clinical and clinical trials. Today, artificial intelligence (AI) and deep learning (DL) are actively transforming vaccine and immunotherapeutic research by (i) offering predictive frameworks that support rapid, data-driven decision-making, (ii) integrating computational models, systems vaccinology, and multi-omics data (iii) helping to better phenotype, differentiate, and classify patients diseases and cancers; (iv), integrating host characteristics for tailored vaccines and immunotherapeutics; (v) refining the selection of B-and T-cell antigen\/epitope targets to enhance efficacy and durability of immune protection; and (vi) enabling a deeper understanding of immune regulation, immune evasion, and regulatory pathways. Artificial intelligence and DL are pushing the boundaries toward (i) the potential replacement of animal preclinical testing of vaccines and immunotherapeutics with computational-based models, as recently proposed by the United States NIH and FDA, and (ii) improving clinical trials by enabling real-time modeling for immune-bridging, predicting patients\u2019 immune responses, safety, and protective efficacy to vaccines and immunotherapeutics. In this review, we describe the past and current applications of AI and DL as time-and resource-efficient strategies and discuss future challenges in implementing AI and DL as new transformative fields that may facilitate the rapid development of precision and personalized vaccines and immunotherapeutics for infectious diseases and cancers.\n                  <\/jats:p>","DOI":"10.3389\/frai.2025.1620572","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:25:04Z","timestamp":1752816304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics\u2014yesterday, today, and tomorrow"],"prefix":"10.3389","volume":"8","author":[{"given":"Elhoucine","family":"Elfatimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassir","family":"Lekbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swayam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lbachir","family":"BenMohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1502484","DOI":"10.3389\/fimmu.2025.1502484","article-title":"Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions","volume":"16","author":"Anderson","year":"2025","journal-title":"Front. Immunol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/pathogens10081048","article-title":"Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19","volume":"10","author":"Arora","year":"2021","journal-title":"Pathogens"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12859-024-05754-1","article-title":"Deepvirusclassifier: a deep learning tool for classifying SARS-CoV-2 based on viral subtypes within the coronaviridae family","volume":"25","author":"Azevedo","year":"2024","journal-title":"BMC Bioinformatics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/s0161-6420(13)31155-5","article-title":"Herpetic eye disease study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis","volume":"101","author":"Barron","year":"1994","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-21-0090","article-title":"Artificial intelligence in Cancer research and precision medicine","volume":"11","author":"Bhinder","year":"2021","journal-title":"Cancer Discov."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1109\/TCBB.2021.3115353","article-title":"An attention based bidirectional LSTM method to predict the binding of TCR and epitope","volume":"19","author":"Bi","year":"2022","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Birkir","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1002\/alz.13412","article-title":"Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review","volume":"19","author":"Borchert","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11538-023-01190-z","article-title":"Mathematical characterization of private and public immune receptor sequences","volume":"85","author":"Bottcher","year":"2023","journal-title":"Bull. Math. Biol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2567.2005.02142.x","article-title":"Immunology and mathematics: crossing the divide","volume":"115","author":"Callard","year":"2005","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1008519","DOI":"10.1371\/journal.pcbi.1008519","article-title":"Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment","volume":"16","author":"Cess","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"17508","DOI":"10.1038\/s41598-018-35452-x","article-title":"Identification of immune signatures of novel adjuvant formulations using machine learning","volume":"8","author":"Chaudhury","year":"2018","journal-title":"Sci. Rep."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.vaccine.2008.11.109","article-title":"A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and naive responses","volume":"27","author":"Cheng","year":"2009","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1128\/JVI.00587-11","article-title":"The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism","volume":"85","author":"Chentoufi","year":"2011","journal-title":"J. Virol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/2666796701999200915142539","article-title":"Prediction of infection and death ratio of COVID-19 virus in Turkey by using artificial neural network (ANN)","volume":"2","author":"\u00c7olak","year":"2021","journal-title":"Coronaviruses"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1343716","DOI":"10.3389\/fimmu.2024.1343716","article-title":"High frequencies of alpha common cold coronavirus\/SARS-CoV-2 cross-reactive functional CD4(+) and CD8(+) memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients","volume":"15","author":"Coulon","year":"2024","journal-title":"Front. Immunol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1128\/JVI.78.20.11340-11351.2004","article-title":"Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus","volume":"78","author":"Davenport","year":"2004","journal-title":"J. Virol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.3768","article-title":"Systems immunology: just getting started","volume":"18","author":"Davis","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41590-022-01292-1","article-title":"Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2","volume":"23","author":"Diniz","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2021.02.006","article-title":"Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies","volume":"232","author":"Dobano","year":"2021","journal-title":"Transl. Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e169860","DOI":"10.1172\/jci.insight.169860","article-title":"A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection","volume":"8","author":"Dogra","year":"2023","journal-title":"JCI Insight"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s11538-016-0214-9","article-title":"Mathematical models for immunology: current state of the art and future research directions","volume":"78","author":"Eftimie","year":"2016","journal-title":"Bull. Math. Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","article-title":"Exploiting machine learning for end-to-end drug discovery and development","volume":"18","author":"Ekins","year":"2019","journal-title":"Nat. Mater."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2297553","DOI":"10.1080\/22221751.2023.2297553","article-title":"The impact of S2 mutations on omicron SARS-CoV-2 cell surface expression and fusogenicity","volume":"13","author":"Escalera","year":"2024","journal-title":"Emerg. Microbes. Infect."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/msb.2010.90","article-title":"Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response","volume":"6","author":"Feinerman","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref28","first-page":"167","article-title":"Immunoinformatics and the prediction of immunogenicity","volume":"1","author":"Flower","year":"2002","journal-title":"Appl. Bioinforma."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e15959","DOI":"10.1371\/journal.pone.0015959","article-title":"Killing of targets by CD8 T cells in the mouse spleen follows the law of mass action","volume":"6","author":"Ganusov","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1016\/j.cell.2024.09.022","article-title":"Empowering biomedical discovery with AI agents","volume":"187","author":"Gao","year":"2024","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.3390\/jcm13216537","article-title":"Next-generation immunotherapy: advancing clinical applications in Cancer treatment","volume":"13","author":"Garg","year":"2024","journal-title":"J. Clin. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"eadu3791","DOI":"10.1126\/scitranslmed.adu3791","article-title":"Vaccinology in the artificial intelligence era","volume":"17","author":"Gasperini","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fimmu.2019.00230","article-title":"Model-based assessment of the role of uneven partitioning of molecular content on heterogeneity and regulation of differentiation in CD8 T-cell immune responses","volume":"10","author":"Girel","year":"2019","journal-title":"Front. Immunol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.it.2015.09.006","article-title":"Bioinformatic and statistical analysis of adaptive immune repertoires","volume":"36","author":"Greiff","year":"2015","journal-title":"Trends Immunol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-immunol-042718-041407","article-title":"Emerging cellular therapies for Cancer","volume":"37","author":"Guedan","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1177\/15353702231209421","article-title":"Review of machine learning and deep learning models for toxicity prediction","volume":"248","author":"Guo","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12879-024-09775-2","article-title":"Reverse vaccinology approaches to design a potent multiepitope vaccine against the HIV whole genome: immunoinformatic, bioinformatics, and molecular dynamics approaches","volume":"24","author":"Hashempour","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2019.12.007","article-title":"Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges","volume":"471","author":"Huang","year":"2020","journal-title":"Cancer Lett."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023141118","article-title":"Deep generative selection models of T and B cell receptor repertoires with soNNia","volume":"118","author":"Isacchini","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature03337","article-title":"CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death","volume":"434","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"btae547","DOI":"10.1093\/bioinformatics\/btae547","article-title":"NeoaPred: a deep-learning framework for predicting immunogenic neoantigen based on surface and structural features of peptide-human leukocyte antigen complexes","volume":"40","author":"Jiang","year":"2024","journal-title":"Bioinformatics"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","article-title":"Artificial intelligence in drug discovery: recent advances and future perspectives","volume":"16","author":"Jimenez-Luna","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1541942","DOI":"10.3389\/fmicb.2025.1541942","article-title":"AI applications in HIV research: advances and future directions","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2014.09.007","article-title":"CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection","volume":"41","author":"Laidlaw","year":"2014","journal-title":"Immunity"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archopht.121.1.108","article-title":"Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis","volume":"121","author":"Lairson","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab160","article-title":"DeepImmuno: deep learning-empowered prediction and generation of immunogenic peptides for T-cell immunity","volume":"22","author":"Li","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2023.02.007","article-title":"Artificial intelligence in cancer immunotherapy: applications in neoantigen recognition, antibody design and immunotherapy response prediction","volume":"91","author":"Li","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41746-024-01043-6","article-title":"Informing immunotherapy with multi-omics driven machine learning","volume":"7","author":"Li","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"241cm245","DOI":"10.1126\/scitranslmed.3008228","article-title":"Parallel discovery of Alzheimer's therapeutics","volume":"6","author":"Lo","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-021-03512-4","article-title":"AI-based pathology predicts origins for cancers of unknown primary","volume":"594","author":"Lu","year":"2021","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0160124","DOI":"10.1128\/jvi.01601-24","article-title":"Pathogen genomic surveillance and the AI revolution","volume":"99","author":"Lytras","year":"2025","journal-title":"J. Virol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.3390\/ijerph18157890","article-title":"Leveraging artificial intelligence and big data to optimize COVID-19 clinical public health and vaccination roll-out strategies in Africa","volume":"18","author":"Mellado","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1128\/JVI.00266-10","article-title":"Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza a virus","volume":"84","author":"Miao","year":"2010","journal-title":"J. Virol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fimmu.2018.00224","article-title":"Computational strategies for dissecting the high-dimensional complexity of adaptive immune repertoires","volume":"9","author":"Miho","year":"2018","journal-title":"Front. Immunol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s42003-021-02610-3","article-title":"Nettcr-2.0 enables accurate prediction of TCR-peptide binding by using paired TCR\u03b1 and \u03b2 sequence data","volume":"4","author":"Montemurro","year":"2021","journal-title":"Commun. Biol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"106998","DOI":"10.1016\/j.mimet.2024.106998","article-title":"Leveraging artificial intelligence in vaccine development: a narrative review","volume":"224","author":"Olawade","year":"2024","journal-title":"J. Microbiol. Methods"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1093\/bioinformatics\/btaa119","article-title":"Vaxign-ML: supervised machine learning reverse vaccinology model for improved prediction of bacterial protective antigens","volume":"36","author":"Ong","year":"","journal-title":"Bioinformatics"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"","journal-title":"Front. Immunol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"7786","DOI":"10.3390\/s21237786","article-title":"A study of the recent trends of immunology: key challenges, domains, applications, datasets, and future directions","volume":"21","author":"Pandya","year":"2021","journal-title":"Sensors (Basel)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biotechadv.2009.10.001","article-title":"Vaccine protocols optimization: in silico experiences","volume":"28","author":"Pappalardo","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"vbad042","DOI":"10.1093\/bioadv\/vbad042","article-title":"Epibertope: a sequence-based pre-trained BERT model improves linear and structural epitope prediction by learning long-distance protein interactions effectively","volume":"3","author":"Park","year":"2023","journal-title":"Bioinformatics Adv."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J. Immunol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ajo.2005.10.008","article-title":"Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy","volume":"141","author":"Pepose","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-immunol-082119-124838","article-title":"T cell epitope predictions","volume":"38","author":"Peters","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.14.580225","article-title":"A broad-spectrum multi-antigen mRNA\/LNP-based pan-coronavirus vaccine induced potent cross-protective immunity against infection and disease caused by highly pathogenic and heavily spike-mutated SARS-CoV-2 variants of concern in the Syrian hamster model","author":"Prakash","year":"","journal-title":"bio Rxiv"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1328905","DOI":"10.3389\/fimmu.2024.1328905","article-title":"Cross-protection induced by highly conserved human B, CD4(+), and CD8(+) T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern","volume":"15","author":"Prakash","year":"","journal-title":"Front. Immunol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.4049\/jimmunol.2001438","article-title":"Genome-wide B cell, CD4(+), and CD8(+) T cell epitopes that are highly conserved between human and animal coronaviruses, identified from SARS-CoV-2 as targets for preemptive Pan-coronavirus vaccines","volume":"206","author":"Prakash","year":"2021","journal-title":"J. Immunol."},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay4014","article-title":"The science and medicine of human immunology","volume":"369","author":"Pulendran","year":"2020","journal-title":"Science"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1426173","DOI":"10.3389\/fimmu.2024.1426173","article-title":"TCR-H: explainable machine learning prediction of T-cell receptor epitope binding on unseen datasets","volume":"15","author":"Rajeshwar","year":"2024","journal-title":"Front. Immunol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"105401","DOI":"10.1016\/j.compbiomed.2022.105401","article-title":"Vaxi-DL: a web-based deep learning server to identify potential vaccine candidates","volume":"145","author":"Rawal","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"042801","DOI":"10.1117\/1.JMI.7.4.042801","article-title":"Virtual clinical trials: why and what (special section guest editorial)","volume":"7","author":"Samei","year":"2020","journal-title":"J. Med. Imaging (Bellingham)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"503","DOI":"10.14283\/jpad.2021.39","article-title":"Cohort-specific optimization of models predicting preclinical Alzheimer's disease, to enhance screening performance in the middle of preclinical Alzheimer's disease clinical studies","volume":"8","author":"Sato","year":"2021","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41592-021-01308-y","article-title":"MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging","volume":"19","author":"Schapiro","year":"2022","journal-title":"Nat. Methods"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nj7345-113a","article-title":"Systems immunology: complexity captured","volume":"473","author":"Schubert","year":"2011","journal-title":"Nature"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41577-022-00740-1","article-title":"Swarm immunology: harnessing blockchain technology and artificial intelligence in human immunology","volume":"22","author":"Schultze","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.rinp.2022.105613","article-title":"Comparative study of artificial neural network versus parametric method in COVID-19 data analysis","volume":"38","author":"Shafiq","year":"2022","journal-title":"Results Phys."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e44359","DOI":"10.7759\/cureus.44359","article-title":"Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.humimm.2008.05.001","article-title":"Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies","volume":"69","author":"Solberg","year":"2008","journal-title":"Hum. Immunol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pathogens2010071","article-title":"Immune evasion, immunopathology and the regulation of the immune system","volume":"2","author":"Sorci","year":"2013","journal-title":"Pathogens"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3390\/vaccines10101678","article-title":"Integralvac: a machine learning-based comprehensive multivalent epitope vaccine design method","volume":"10","author":"Suri","year":"2022","journal-title":"Vaccines (Basel)."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jcrs.2013.06.005","article-title":"Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom","volume":"39","author":"Sykakis","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1488050","DOI":"10.3389\/fnagi.2024.1488050","article-title":"Advanced AI techniques for classifying Alzheimer's disease and mild cognitive impairment","volume":"16","author":"Tascedda","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jtbi.2011.08.036","article-title":"Spatio-temporal modelling of the NF-kappaB intracellular signalling pathway: the roles of diffusion, active transport, and cell geometry","volume":"290","author":"Terry","year":"2011","journal-title":"J. Theor. Biol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-0716-1884-4_6","article-title":"Artificial Intelligence in Vaccine and Drug Design","volume":"2410","author":"Thomas","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and Cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune Netw."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e1000246","DOI":"10.1371\/journal.pcbi.1000246","article-title":"A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines","volume":"4","author":"Toussaint","year":"2008","journal-title":"PLoS Comput. Biol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.08.602409","article-title":"A variational deep-learning approach to modeling memory T cell dynamics","author":"van Dorp","year":"2025","journal-title":"bio Rxiv"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1146\/annurev-immunol-042617-053035","article-title":"Systems immunology: learning the rules of the immune system","volume":"36","author":"Villani","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.21037\/tcr-22-2782","article-title":"Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cotox.2020.06.003","article-title":"DILIsym: quantitative systems toxicology impacting drug development","author":"Watkins","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development investment needed to bring a new medicine to market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1101443","article-title":"Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors","volume":"187","author":"Wu","year":"2011","journal-title":"J. Immunol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1016\/j.apsb.2021.02.007","article-title":"Applying artificial intelligence for cancer immunotherapy","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41591-024-03398-5","article-title":"Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data","volume":"31","author":"Yoo","year":"2025","journal-title":"Nat. Med."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1503954","DOI":"10.3389\/fimmu.2025.1503954","article-title":"Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19","volume":"16","author":"Zayou","year":"2025","journal-title":"Front. Immunol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2147\/JMDH.S410301","article-title":"Machine learning and AI in Cancer prognosis, prediction, and treatment selection: a critical approach","volume":"16","author":"Zhang","year":"","journal-title":"J. Multidiscip. Healthc."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1141535","DOI":"10.3389\/fgene.2023.1141535","article-title":"iTCep: a deep learning framework for identification of T cell epitopes by harnessing fusion features","volume":"14","author":"Zhang","year":"","journal-title":"Front. Genet."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"2429893","DOI":"10.1080\/21645515.2024.2429893","article-title":"The role of artificial intelligence in immune checkpoint inhibitor research: a bibliometric analysis","volume":"20","author":"Zhao","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175824","article-title":"FDA modernization act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Artificial Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2025.1620572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:25:06Z","timestamp":1752816306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2025.1620572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":111,"alternative-id":["10.3389\/frai.2025.1620572"],"URL":"https:\/\/doi.org\/10.3389\/frai.2025.1620572","relation":{},"ISSN":["2624-8212"],"issn-type":[{"value":"2624-8212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"1620572"}}